QuantLogix's current estimate for Cerebral, published 2026-09-27 — in line with the last disclosed round of $4.8B (2021-Q4).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$4.8B
2021-Q4
weight 0.04
Secondary market print
$4.8B
2026-06-27
weight 0.58
How this price has held up
No round has priced for Cerebral since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Cerebral, 2026-09-27 (b133ee81d8e8e578).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Cerebral going public?
No. Cerebral is private and has not filed to go public. There is no S-1 on file.
What is Cerebral's valuation in 2026?
Cerebral is valued at $4.8B as of 2021-Q4, set by its Series C ($300M, Dec 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Cerebral filed an S-1?
No public S-1 is on file for Cerebral.
How much has Cerebral raised?
Cerebral has raised $461.4M in total, most recently a Series C of $300M in Dec 2021.
Is Cerebral publicly traded — can you buy Cerebral stock?
No. Cerebral is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Cerebral on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2020
HQ
Claymont, DE
Employees
2,215
Total Raised
$461.4M
Last Round
Series C — $300M (Dec 2021)
IPO Status
private
Fundraising Status
Series C · $300M · 4y 9mo ago
privateTotal raised $461.4M
Secondary Market
Implied price / share
$2.55
Open interest
2
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. The feed’s last-round price for this company is not a plausible per-share figure, so no comparison is shown. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$300M
Dec 2021
—
$4.8B
Talent Signal
Hiring trend
▶ Hiring steady
0% vs 2026-08
Open roles
6
via careers page
Product-build share
67%
engineering, research, product, design
Trajectory
steady
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 3 of 6 open roles are medical.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Find a therapist![right chevron arrowNurse PractitionersOur ResearchData-driven outcomes and focus on clinical qualitySee what else people are sayingSupportive clinical community
Counted from Cerebral's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareMedicalmHealthWellness
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.